{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:49:42Z","timestamp":1790804982942,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Biomedical Informatics Centre (BMIC)","award":["BIC\/NTF\/1\/2012-13"],"award-info":[{"award-number":["BIC\/NTF\/1\/2012-13"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jmgm.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:29:14Z","timestamp":1522848554000},"page":"20-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1838-122X","authenticated-orcid":false,"given":"Manne","family":"Munikumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagolu Siva","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-4676","authenticated-orcid":false,"given":"Varikasuvu Seshadri","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolla","family":"Rajeswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmarajan","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mendu Vishnuvardhana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxm012","article-title":"The global epidemic of obesity: an overview","volume":"29","author":"Caballero","year":"2007","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.jmgm.2018.04.002_bib2","series-title":"World Health Organization Fact Sheet","author":"WHO","year":"2016"},{"issue":"Suppl 1","key":"10.1016\/j.jmgm.2018.04.002_bib3","first-page":"S1","volume":"17","author":"Mechanick","year":"2009","journal-title":"Obesity (Silver Spring, Md.)"},{"issue":"Suppl 1","key":"10.1016\/j.jmgm.2018.04.002_bib4","first-page":"S1","volume":"21","author":"Mechanick","year":"2013","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"10.1016\/j.jmgm.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mehy.2016.04.032","article-title":"Leptin inhibitors from fungal endophytes (LIFEs): will be novel therapeutic drugs for obesity and its associated immune mediated diseases","volume":"92","author":"Chandra Mouli","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jmgm.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2310\/JIM.0b013e3181bb0d49","article-title":"Central leptin receptor action and resistance in obesity","volume":"57","author":"Bjorbaek","year":"2009","journal-title":"J.\u00a0Invest. Med.: Offic. Publ. Am. Fed. Clin. Res."},{"key":"10.1016\/j.jmgm.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijcard.2009.07.019","article-title":"Leptin and the clinical cardiovascular risk","volume":"140","author":"Singh","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib8","first-page":"822","article-title":"Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle intervention","volume":"139","author":"Sarvottam","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jmgm.2018.04.002_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/mend.11.4.9907","article-title":"The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line","volume":"11","author":"Ghilardi","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib10","doi-asserted-by":"crossref","first-page":"14563","DOI":"10.1074\/jbc.275.19.14563","article-title":"Activation of downstream signals by the long form of the leptin receptor","volume":"275","author":"Banks","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/BJ20041621","article-title":"Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line","volume":"388","author":"Benomar","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmgm.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"28691","DOI":"10.1074\/jbc.273.44.28691","article-title":"Human leptin receptor. Determination of disulfide structure and N-glycosylation sites of the extracellular domain","volume":"273","author":"Haniu","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"22632","DOI":"10.1074\/jbc.M413308200","article-title":"Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains","volume":"280","author":"Zabeau","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20050233","article-title":"Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor","volume":"390","author":"Niv-Spector","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmgm.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1074\/jbc.M512622200","article-title":"Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex","volume":"281","author":"Peelman","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"26604","DOI":"10.1074\/jbc.M302002200","article-title":"Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers","volume":"278","author":"Couturier","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy","volume":"19","author":"Schett","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmgm.2018.04.002_bib18","first-page":"481","article-title":"Repositioning leptin as a therapy for Alzheimer's disease","volume":"8","author":"Johnston","year":"2011","journal-title":"Therapy (Lond.)"},{"key":"10.1016\/j.jmgm.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ph5020209","article-title":"Structure based antibody-like peptidomimetics","volume":"5","author":"Murali","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0167-5699(00)01680-7","article-title":"Antibody humanization: a case of the 'Emperor's new clothes'?","volume":"21","author":"Clark","year":"2000","journal-title":"Immunol. today"},{"key":"10.1016\/j.jmgm.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jim.2006.03.011","article-title":"Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation","volume":"312","author":"Fazeli","year":"2006","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.jmgm.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/ENDO:21:2:185","article-title":"A\u00a0peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells","volume":"21","author":"Gonzalez","year":"2003","journal-title":"Endocrine"},{"key":"10.1016\/j.jmgm.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/en.2004-1186","article-title":"Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process","volume":"146","author":"Ramos","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmgm.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/ja1071916","article-title":"Universal peptidomimetics","volume":"133","author":"Ko","year":"2011","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2018.04.002_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/jm3015298","article-title":"Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction","volume":"56","author":"Zhou","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12539-013-0161-1","article-title":"Computational approaches to identify common subunit vaccine candidates against bacterial meningitis","volume":"5","author":"Munikumar","year":"2013","journal-title":"Interdiscipl. Sci. Comput. Life Sci."},{"key":"10.1016\/j.jmgm.2018.04.002_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/07391102.2013.786419","article-title":"177 T-cell vaccine design forStreptococcus pneumoniae: anin silicoapproach","volume":"31","author":"Munikumar","year":"2013","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2018.04.002_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.peptides.2013.03.027","article-title":"Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity","volume":"44","author":"Beccari","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.jmgm.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bip.21377","article-title":"Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation","volume":"96","author":"Otvos","year":"2011","journal-title":"Biopolymers"},{"key":"10.1016\/j.jmgm.2018.04.002_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/72651","article-title":"Rationally designed anti-HER2\/neu peptide mimetic disables P185HER2\/neu tyrosine kinases in\u00a0vitro and in\u00a0vivo","volume":"18","author":"Park","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib31","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/jm000527m","article-title":"Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis","volume":"44","author":"Berezov","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib32","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.bmcl.2011.02.013","article-title":"Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent","volume":"21","author":"Ponde","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2018.04.002_bib33","first-page":"301","article-title":"Therapeutic antibodies for autoimmunity and inflammation. Nature reviews","volume":"10","author":"Chan","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jmgm.2018.04.002_bib34","doi-asserted-by":"crossref","first-page":"E2656","DOI":"10.1073\/pnas.1401131111","article-title":"Origins of specificity and affinity in antibody-protein interactions","volume":"111","author":"Peng","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jmgm.2018.04.002_bib35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/07391102.2013.795871","article-title":"Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis","volume":"32","author":"Priyadarshini","year":"2014","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.str.2012.01.019","article-title":"Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody","volume":"20","author":"Carpenter","year":"2012","journal-title":"Structure (Lond.)"},{"key":"10.1016\/j.jmgm.2018.04.002_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib38","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gks480","article-title":"Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure","volume":"40","author":"Kunik","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.04.002_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10799893.2016.1147584","article-title":"Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases","volume":"36","author":"Verma","year":"2016","journal-title":"J.\u00a0Recept. Signal Transduct. Res."},{"key":"10.1016\/j.jmgm.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/ci700358r","article-title":"Computational validation of the importance of absolute stereochemistry in virtual screening","volume":"48","author":"Brooks","year":"2008","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.04.002_bib41","first-page":"01","article-title":"In silico identification of common putative drug targets among the pathogens of bacterial meningitis","author":"Munikumar","year":"2012","journal-title":"Biochem. Anal. Biochem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1128\/AAC.00689-08","article-title":"GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in\u00a0vitro","volume":"53","author":"Koh","year":"2009","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.jmgm.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jtbi.2013.05.014","article-title":"Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors","volume":"334","author":"Tripathi","year":"2013","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1021\/ci900320p","article-title":"Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model","volume":"49","author":"Das","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.04.002_bib45","doi-asserted-by":"crossref","first-page":"46304","DOI":"10.1074\/jbc.M207556200","article-title":"Subcloning, expression, purification, and characterization of recombinant human leptin-binding domain","volume":"277","author":"Sandowski","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.04.002_bib46","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1242\/jcs.02386","article-title":"Mapping of the interface between leptin and the leptin receptor CRH2 domain","volume":"118","author":"Iserentant","year":"2005","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jmgm.2018.04.002_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2013.00302","article-title":"The structural basis of antibody-antigen recognition","volume":"4","author":"Sela-Culang","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmgm.2018.04.002_bib48","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0400060101","article-title":"Structural mechanism for affinity maturation of an anti-lysozyme antibody","volume":"101","author":"Cauerhff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jmgm.2018.04.002_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00894-006-0127-x","article-title":"Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations","volume":"13","author":"Zhang","year":"2007","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.jmgm.2018.04.002_bib50","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/ci4003409","article-title":"Combining solvent thermodynamic profiles with functionality maps of the Hsp90 binding site to predict the displacement of water molecules","volume":"53","author":"Haider","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631830055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109332631830055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:57:11Z","timestamp":1761080231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109332631830055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":50,"alternative-id":["S109332631830055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.04.002","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}